Featured Research

from universities, journals, and other organizations

Anti-cancer drug kicks HIV out of hiding

Date:
July 22, 2014
Source:
Aarhus University
Summary:
An anti-cancer drug can activate hidden HIV, a pilot study by HIV researchers has shown. The researchers found that the anti-cancer drug romidepsin increased the virus production in HIV-infected cells between 2.1 and 3.9 times above normal and that the viral load in the blood increased to measurable levels in five out of six patients with HIV infection.

A pilot study by HIV researchers from Aarhus University and Aarhus University Hospital in Denmark has shown that an anti-cancer drug can activate hidden HIV. The researchers found that the anti-cancer drug romidepsin increased the virus production in HIV-infected cells between 2.1 and 3.9 times above normal and that the viral load in the blood increased to measurable levels in five out of six patients with HIV infection.

A pilot study

The results were presented today as breaking news at the annual international AIDS conference in Melbourne, Australia. The pilot study is part of a larger study investigating the possibilities of combining activation of HIV and a vaccine to strengthen the ability of the immune system to fight HIV.

The group of researchers from Aarhus University and Aarhus University Hospital has previously shown that the drug panobinostat can activate hidden HIV in the cells but for the first time the researchers have been demonstrated that it is possible to activate hidden virus to levels readably detectable in the blood by standard methods.

Activated HIV leaves traces

HIV can hide in a "state of hibernation" in the so-called CD4 cells. These cells are a part of the body's immune system, but the CD4 cells cannot fight the virus themselves; killer T-cells can. However, killer T-cells cannot tell if a CD4 cell contains "hibernating" HIV virus. That is why HIV continues to be a chronic disease. HIV infection can be kept down by medicine but there is still no cure which can eradicate HIV from the body.

The results presented by the researchers at Aarhus University Hospital and Aarhus University are interesting; when the virus is activated and moves towards the bloodstream it leaves a trace on the outside of the infected CD4 cells. In principle this means that the killer T cells can now trace and destroy the HIV-infected CD4 cells.

Immune system is not strong enough

In addition to measuring the increased viral load in six HIV-infected test persons, the researchers have tested the side effects of the medicine. The test persons experienced transient fatigue and nausea, which are known side effects of romidepsin. And so, the pilot study does not cause immediate concern for special side effects in HIV-infected persons.

Moreover, the researchers have investigated if the total HIV reservoir in the body is lowered when the killer T-cells are now able to trace and destroy the HIV-infected CD4 cells. However, the researchers have not been able to demonstrate that.

The immune system's reaction to the exposed HIV-infected cells may not itself be strong enough to clear the cells from the body. But the mechanism to activate and expose the HIV virus may potentially one day be part of a combination of drugs which together can eradicate HIV infection, says senior researcher and medical doctor Ole Schmeltz Sψgaard.

Still a long way to go

The next step is a bigger trial where the researchers will combine romidepsin activation of hidden HIV with a vaccine (vacc-4x) to strengthen the ability of killer T-cells to fight hiv virus.

We have now shown that we can activate a hibernating virus with romidepsin and that the activated virus moves into the bloodstream in large amounts. This is a step in the right direction; but there is still a long way to go and many obstacles to overcome before we can start talking about a cure against HIV, says Ole Schmeltz Sψgaard.


Story Source:

The above story is based on materials provided by Aarhus University. Note: Materials may be edited for content and length.


Cite This Page:

Aarhus University. "Anti-cancer drug kicks HIV out of hiding." ScienceDaily. ScienceDaily, 22 July 2014. <www.sciencedaily.com/releases/2014/07/140722102249.htm>.
Aarhus University. (2014, July 22). Anti-cancer drug kicks HIV out of hiding. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/07/140722102249.htm
Aarhus University. "Anti-cancer drug kicks HIV out of hiding." ScienceDaily. www.sciencedaily.com/releases/2014/07/140722102249.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins